NIS Labs
Klamath Falls, Oregon, 97601, United States
Location status: Recruiting
NCT Number: NCT07314359
The goal for this clinical proof-of-concept study is to compare an active biofield skin patch to a placebo patch on antioxidant function and mitochondrial function. A double-blind, placebo-controlled cross-over study design will be used.
Interested in participating?
Request Info18 year–75 year
All sexes
Interventional
Not applicable
Klamath Falls, Oregon, 97601, United States
Location status: Recruiting
The goal for this clinical proof-of-concept study is to document acute effects of a photobiomodulating non-transdermal patch compared to a placebo patch, in an acute randomized double-blind placebo-controlled cross-over design. An add-on open-label module involves wearing the active patch daily for a week before the final clinic visit.
Data on endogenous antioxidant protection will be collected. The testing will show whether wearing the patch leads to a change in antioxidant activity of superoxide dismutase and glutathione. Data on cellular energy production and mitochondrial resilience in white blood cells under oxidative and inflammatory stress ex vivo will be collected. This testing will show whether using the active patch leads to changes in mitochondrial biogenesis and mitochondrial energy production under normal versus ex vivo-stressed conditions. Data on serum cytokine levels in both serum and serum-derived extracellular vesicles will be collected. The testing will show whether wearing the patch contributes to rapid change in pro- and anti-inflammatory markers and restorative growth factors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-transdermal patch
Non-transdermal patch
Time frame: Baseline, 1 hour, and 2 hours after applying a patch.
Data will be collected on intracellular levels of reduced glutathione and serum superoxide dismutase activity.
Time frame: Baseline, 1 hour, and 2 hours after applying a patch.
Mitochondrial volume per cell, measured by flow cytometry where the mean fluorescence intensity (MFI) is quantified on lymphocytes, monocytes, and polymorphonuclear cells. White blood cells are purified and cultured ex vivo in unstressed versus inflamed culture conditions. The mitochondrial reporter dye MitoTracker is used to obtain relative measures of mitochondrial volume per cell.
Time frame: Baseline, 1 hour, and 2 hours after applying a patch
Cellular energy production as a function of the mitochondrial membrane potential where the mean fluorescence intensity (MFI) is quantified on lymphocytes, monocytes, and polymorphonuclear cells. White blood cells are purified and cultured ex vivo in unstressed versus inflamed culture conditions. The mitochondrial reporter dye JC-1 is a fluorescent cationic dye used to obtain relative measures of mitochondrial membrane potential per cell.
Time frame: Baseline, 1 hour, and 2 hours after applying a patch.
Data on serum levels of 27 pro- and anti-inflammatory cytokines and regenerative growth factors will be collected.
Time frame: Baseline, 1 hour, and 2 hours after applying a patch.
Data on the levels of 27 pro- and anti-inflammatory cytokines and regenerative growth factors in serum extracellular vesicles will be collected.
Contact information is provided by the study sponsor or research team.
Natural Immune Systems Inc
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04523675
Antioxidant Status, Exercise-induced Aseptic Inflammation
Trikala, Greece
View Trial Details